Trial intelligence / Profile preview

Exploratory Study of OPH in Dry Eye–Related Keratoconjunctival Epithelial Disorders

jRCT2080222972Phase 2

Sponsor
Ophtecs
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in dry eye syndrome (DED) and Keratoconjunctivitis (KC) comparing OPH with Placebo (2 arms).

02

Drugs

oxyphenbutazone
03

Conditions

dry eye syndrome (DED)Keratoconjunctivitis (KC)

Beyond the preview

Go deeper on jRCT2080222972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call